- Home
- WVE vs NVG Comparison
WVE vs NVG Comparison
Compare WVE & NVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WVE
- NVG
- Stock Information
- Founded
- WVE 2012
- NVG 1999
- Country
- WVE Singapore
- NVG United States
- Employees
- WVE N/A
- NVG N/A
- Industry
- WVE Biotechnology: Pharmaceutical Preparations
- NVG Investment Managers
- Sector
- WVE Health Care
- NVG Finance
- Exchange
- WVE Nasdaq
- NVG Nasdaq
- Market Cap
- WVE 2.4B
- NVG 2.7B
- IPO Year
- WVE 2015
- NVG N/A
- Fundamental
- Price
- WVE $13.67
- NVG $12.87
- Analyst Decision
- WVE Strong Buy
- NVG
- Analyst Count
- WVE 10
- NVG 0
- Target Price
- WVE $21.30
- NVG N/A
- AVG Volume (30 Days)
- WVE 1.4M
- NVG 568.8K
- Earning Date
- WVE 11-12-2024
- NVG 01-01-0001
- Dividend Yield
- WVE N/A
- NVG 4.65%
- EPS Growth
- WVE N/A
- NVG N/A
- EPS
- WVE N/A
- NVG N/A
- Revenue
- WVE $53,610,000.00
- NVG N/A
- Revenue This Year
- WVE N/A
- NVG N/A
- Revenue Next Year
- WVE N/A
- NVG N/A
- P/E Ratio
- WVE N/A
- NVG N/A
- Revenue Growth
- WVE N/A
- NVG N/A
- 52 Week Low
- WVE $3.50
- NVG $9.68
- 52 Week High
- WVE $16.74
- NVG $12.21
- Technical
- Relative Strength Index (RSI)
- WVE 50.96
- NVG 49.07
- Support Level
- WVE $14.95
- NVG $12.71
- Resistance Level
- WVE $16.71
- NVG $13.08
- Average True Range (ATR)
- WVE 1.04
- NVG 0.15
- MACD
- WVE -0.28
- NVG 0.05
- Stochastic Oscillator
- WVE 14.72
- NVG 68.84
About WVE Wave Life Sciences Ltd.
WAVE Life Sciences Ltd is unlocking the broad potential of RNA medicines also known as oligonucleotides, it targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISMTM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, splicing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
About NVG Nuveen AMT-Free Municipal Credit Income Fund
Nuveen AMT-Free Municipal Credit Income Fund is a diversified, closed-end management investment company. Its objective is to provide current income exempt from regular federal income tax. The Fund invests predominantly in investment grade municipal bonds that are exempt from regular federal income taxes.